{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:22:52Z","timestamp":1791433372368,"version":"4.3.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515012481"],"award-info":[{"award-number":["2025A1515012481"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024B1515040006"],"award-info":[{"award-number":["2024B1515040006"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173392"],"award-info":[{"award-number":["82173392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403670"],"award-info":[{"award-number":["82403670"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024A03J0846"],"award-info":[{"award-number":["2024A03J0846"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ50149"],"award-info":[{"award-number":["2023JJ50149"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.actbio.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:37:27Z","timestamp":1754437047000},"page":"534-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nanoparticle-induced excessive mitophagy combined with immune checkpoint blockade for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"204","author":[{"given":"Yuan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyue","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-6731","authenticated-orcid":false,"given":"Xiaoding","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5256","key":"10.1016\/j.actbio.2025.08.001_bib0001","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.actbio.2025.08.001_bib0002","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.cell.2015.08.038","article-title":"Releasing the brakes on cancer immunotherapy","volume":"162","author":"Littman","year":"2015","journal-title":"Cell"},{"issue":"6382","key":"10.1016\/j.actbio.2025.08.001_bib0003","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.actbio.2025.08.001_bib0004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.actbio.2025.08.001_bib0005","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.actbio.2025.08.001_bib0006","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41568-021-00343-3","article-title":"Overcoming hurdles in cancer immunotherapy","volume":"21","author":"York","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0007","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct.Target. Ther."},{"issue":"6","key":"10.1016\/j.actbio.2025.08.001_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"issue":"7355","key":"10.1016\/j.actbio.2025.08.001_bib0009","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-024-02049-0","article-title":"Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy","volume":"23","author":"Tang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.actbio.2025.08.001_bib0011","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","article-title":"The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis","volume":"20","author":"Yoshimura","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"19","key":"10.1016\/j.actbio.2025.08.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808303","article-title":"Tailoring nanomaterials for targeting tumor-associated macrophages","volume":"31","author":"Ovais","year":"2019","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.actbio.2025.08.001_bib0013","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ccell.2021.04.016","article-title":"The loss of RNA N-6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth","volume":"39","author":"Dong","year":"2021","journal-title":"Cancer Cell."},{"issue":"11","key":"10.1016\/j.actbio.2025.08.001_bib0014","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"40","key":"10.1016\/j.actbio.2025.08.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.actbio.2025.08.001_bib0016","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1078-0432.CCR-23-1316","article-title":"Platinum-based chemotherapy attenuates the effector response of CD8 T cells to concomitant PD-1 blockade","volume":"30","author":"Mariniello","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0017","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/s41467-024-49121-3","article-title":"Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial","volume":"15","author":"Gong","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.actbio.2025.08.001_bib0018","doi-asserted-by":"crossref","first-page":"eaaz4204","DOI":"10.1126\/sciadv.aaz4204","article-title":"Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses","volume":"6","author":"Chao","year":"2020","journal-title":"Sci. Adv."},{"issue":"22","key":"10.1016\/j.actbio.2025.08.001_bib0019","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.actbio.2025.08.001_bib0020","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.actbio.2025.08.001_bib0021","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104705","article-title":"Molecular mechanisms and physiological functions of mitophagy","volume":"40","author":"Onishi","year":"2021","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.actbio.2025.08.001_bib0022","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/onc.2016.302","article-title":"Parkin and mitophagy in cancer","volume":"36","author":"Bernardini","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0024","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.actbio.2025.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.actbio.2025.08.001_bib0026","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2025.08.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121796","article-title":"Engineering mitochondrial uncoupler synergistic photodynamic nanoplatform to harness immunostimulatory pro-death autophagy\/mitophagy","volume":"289","author":"Sun","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.08.001_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1431968","article-title":"Targeting cellular mitophagy as a strategy for human cancers","volume":"12","author":"Dong","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0029","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12935-021-02065-w","article-title":"Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics","volume":"21","author":"Guan","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.actbio.2025.08.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121168","article-title":"Mitochondrial-targeting nanoprodrugs to mutually reinforce metabolic inhibition and autophagy for combating resistant cancer","volume":"278","author":"Sun","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","article-title":"Emerging views of mitophagy in immunity and autoimmune diseases","volume":"16","author":"Xu","year":"2020","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.actbio.2025.08.001_bib0032","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","article-title":"Mitochondrial control of inflammation","volume":"23","author":"Marchi","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.actbio.2025.08.001_bib0033","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nri.2017.66","article-title":"Mitochondrial control of immunity: beyond ATP","volume":"17","author":"Mehta","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0034","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2018.05.028","article-title":"Mitophagy in intestinal epithelial cells triggers adaptive immunity during tumorigenesis","volume":"174","author":"Ziegler","year":"2018","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.actbio.2025.08.001_bib0035","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41388-019-0772-z","article-title":"Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression","volume":"38","author":"Bao","year":"2019","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.actbio.2025.08.001_bib0036","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7150\/thno.79876","article-title":"Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation","volume":"13","author":"Lu","year":"2023","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.actbio.2025.08.001_bib0037","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/bio.2546","article-title":"Comparison of the binding behavior of FCCP with HSA and HTF as determined by spectroscopic and molecular modeling techniques","volume":"29","author":"Moghaddam","year":"2014","journal-title":"Luminescence"},{"issue":"5","key":"10.1016\/j.actbio.2025.08.001_bib0038","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10863-017-9724-x","article-title":"H+ translocation by weak acid uncouplers is independent of H+ electrochemical gradient","volume":"49","author":"Pl\u00e1\u0161ek","year":"2017","journal-title":"J. Bioenerg. Biomembr."},{"issue":"6","key":"10.1016\/j.actbio.2025.08.001_bib0039","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1089\/ars.2008.2331","article-title":"Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function","volume":"11","author":"Stowe","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.actbio.2025.08.001_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri2975","article-title":"Mitochondria in innate immune responses","volume":"11","author":"West","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"29","key":"10.1016\/j.actbio.2025.08.001_bib0041","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1038\/s41388-019-0840-4","article-title":"Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-\u03bab-CCL2 signaling in lung cancer","volume":"38","author":"Zhou","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.actbio.2025.08.001_bib0042","article-title":"Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy","volume":"2","author":"Huang","year":"2022","journal-title":"Exploration"},{"issue":"8","key":"10.1016\/j.actbio.2025.08.001_bib0043","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.apsb.2022.12.004","article-title":"Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis","volume":"13","author":"Yang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.actbio.2025.08.001_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202305923","article-title":"Remodeling of mitochondrial metabolism by a mitochondria-targeted RNAi nanoplatform for effective cancer therapy","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"issue":"19","key":"10.1016\/j.actbio.2025.08.001_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207118","article-title":"Remodeling serine synthesis and metabolism via nanoparticles (NPs)-mediated CFL1 silencing to enhance the sensitivity of hepatocellular carcinoma to sorafenib","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2025.08.001_bib0046","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.actbio.2024.12.061","article-title":"Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy","volume":"193","author":"Huang","year":"2025","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2025.08.001_bib0047","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/AAC.00798-13","article-title":"Effect of a high-calorie, high-fat meal on the bioavailability and pharmacokinetics of PA-824 in healthy adult subjects","volume":"57","author":"Winter","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2025.08.001_bib0048","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcis.2025.01.107","article-title":"Nanoparticles (NPs)-mediated silencing of GSTP1 expression to reverse chemoresistance for effective breast cancer therapy","volume":"685","author":"Shen","year":"2025","journal-title":"Colloid . Interf. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0049","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-025-02274-1","article-title":"Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.actbio.2025.08.001_bib0050","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.febslet.2007.05.064","article-title":"Effects of pH and salt concentration on the siRNA binding activity of the RNA silencing suppressor protein p19","volume":"581","author":"Koukiekolo","year":"2007","journal-title":"FEBS Lett."},{"issue":"30","key":"10.1016\/j.actbio.2025.08.001_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301409","article-title":"Electrostatic attractive self-delivery of siRNA and light-induced self-escape for synergistic gene therapy","volume":"35","author":"Yang","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0052","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12943-019-0961-y","article-title":"Reactive oxygen species: a volatile driver of field cancerization and metastasis","volume":"18","author":"Liao","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0053","article-title":"NF-\u03bab signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.actbio.2025.08.001_bib0054","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/1078-0432.CCR-09-1015","article-title":"Nuclear factor-\u03bab and tumor-associated macrophages","volume":"16","author":"Mancino","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.actbio.2025.08.001_bib0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11010-011-0756-y","article-title":"NF-\u03bab mediates the induction of Fas receptor and Fas ligand by microcystin-LR in HepG2 cells","volume":"352","author":"Feng","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"36","key":"10.1016\/j.actbio.2025.08.001_bib0056","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125005835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125005835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:19:04Z","timestamp":1769617144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125005835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":56,"alternative-id":["S1742706125005835"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.08.001","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-induced excessive mitophagy combined with immune checkpoint blockade for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}